Full-Time

Managing Director

Avalere Health

Avalere Health

201-500 employees

Healthcare consulting with advisory, policy, marketing

Compensation Overview

$200k - $260k/yr

Company Does Not Provide H1B Sponsorship

Remote in USA

Remote

Flexible hybrid/remote; option to work globally two weeks per year.

Category
Consulting (1)
Required Skills
Public Speaking
Requirements
  • 15+ years of experience in health policy, which could include employment by a pharmaceutical company, relevant trade group, advocacy organization, Capitol Hill, the Administration, or professional advisory services.
  • Deep understanding of U.S. healthcare policy, biopharmaceutical market dynamics, and payer/reimbursement structures.
  • Significant experience analyzing policy proposals, legislation, and/or regulation and conveying findings to clients and the public.
  • Proven track record of building and growing successful teams.
Responsibilities
  • Serve as a trusted advisor to executive-level clients across the life sciences, payer, and provider sectors, offering insights on the evolving policy and regulatory landscape impacting pharmaceutical/ biotech, health insurance, pharmacy, and PBM industries.
  • Lead development of new policy service offerings and thought leadership that position Avalere as a recognized leader in healthcare policy strategy.
  • Oversee delivery of high-impact advisory engagements addressing issues such as drug pricing, coverage and access, reimbursement, and other healthcare reform.
  • Engage in frequent public speaking and panel discussion forums as recognized expert across a diverse range of health policy areas.
  • Use expert health policy content knowledge to identify new areas for business growth and steward these opportunities through successful implementation and delivery.
  • Deploy understanding of complex account issues to problem-solve multi-dimensional policy and business interests.
  • Collaborate across Advisory, Medical, and Marketing teams to ensure integration of policy insights into broader client strategies.
  • Act as senior leader on major accounts, ensuring client satisfaction, strategic alignment, and long-term partnership growth.
  • Leverage strong industry networks to open new doors and reinforce Avalere’s position as a trusted policy advisor.
  • Demonstrate expert consulting acumen, deepening client relationships and anticipating client needs and impacts of healthcare landscape changes
  • Direct teams to ensure revenue and business development goals are achieved
  • Participate in account goal planning meetings, using client and healthcare knowledge to contribute to action plans and identify staff to execute
  • Work with Client Partnership team as expert SME and trusted business partner
  • Leverage high quality work to grow client relationships and opportunities
  • Manage, mentor, and grow a high-performing tree of policy strategists and consultants, fostering a culture of excellence, collaboration, and innovation.
  • Lead a significant book of business critical to practice revenue attainment
  • Contribute to plans for growth, acquisition, and retention of talent as well as succession planning
  • Contribute to firmwide strategy and cross-functional initiatives
Desired Qualifications
  • Advanced degree in public policy, public health, business, or a related field preferred.
  • Advanced Microsoft Office skills, including PowerPoint, Excel, and Word.

Avalere Health is a healthcare consulting firm that provides advisory, medical affairs, and marketing services to providers, payers, and life sciences companies. Its offerings help clients navigate the healthcare market through a proprietary SenseMaking model that combines data analysis, policy expertise, and market insights. This approach supports areas such as market access and reimbursement strategies, policy analysis, and government affairs, with revenue generated from consulting fees. The company differentiates itself by applying its SenseMaking framework to deliver targeted, data-backed recommendations across the healthcare ecosystem, integrating policy, market, and clinical considerations for each client. Its goal is to help clients make informed decisions, optimize performance, and achieve their business objectives in a complex and evolving healthcare environment.

Company Size

201-500

Company Stage

Acquired

Total Funding

$140M

Headquarters

null

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Japan office leverages oncology, diabetes, immunology markets for rapid revenue growth.
  • Inovalon acquisition enhances SenseMaking with advanced health data analytics.
  • New hires like Emily Donaldson and Corrina Safeio bolster policy and marketing expertise.

What critics are saying

  • Amar Urhekar's unproven three-pillar strategy fails within 12-24 months against boutiques.
  • C-suite marketing reshuffles with Sarah Hall disrupt client continuity in 6-12 months.
  • Trump 2025 policies collapse US drug pricing advisory revenue in 6-18 months.

What makes Avalere Health unique

  • Proprietary SenseMaking model intersects science, society, and systems for unified strategies.
  • Integrated advisory, medical, and marketing services span full product lifecycle.
  • Global expansion includes Japan office led by Junji Yokokawa targeting oncology growth.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Avalere Health who can refer or advise you

Benefits

Health Insurance

401(k) Retirement Plan

Wellness Program

Paid Vacation

Flexible Work Hours

Hybrid Work Options

Company News

PR Newswire
Jan 14th, 2025
Policy Strategists To Debate 2025 Impact Of The New Administration And Market Changes To Healthcare

Avalere, part of Avalere Health, convenes eleven strategistsWASHINGTON, Jan. 15, 2025 /PRNewswire/ -- Eleven leading policy strategists are scheduled to debate how market changes and the Trump administration will shape 2025, impacting drug pricing, health plan design and patient access to needed therapies. The annual live webinar, "2025 Healthcare Industry Outlook: Opportunity Through Uncertainty" is scheduled for Thursday, January 23 at 11:00 a.m. ET

PharmaLive
Dec 12th, 2024
Amar Urhekar named CEO of Avalere Health

Urhekar joined Avalere Health in 2023 as Chief Operations Officer (COO) to unify the organization and build a global interdisciplinary offering across the product lifecycle.

Haymarket Media
Dec 12th, 2024
Avalere Health elevates Amar Urhekar to CEO post

Avalere Health promoted COO Amar Urhekar to the CEO post on Thursday morning.

HIT Consultant
Dec 11th, 2024
Bridging Healthcare Disparities In Limb Loss Through Data-Driven Strategies

Shawn Murphy, VP, Thought Leadership Innovation Foundation (TLI)Limb loss and limb difference impact millions of people globally, with over 2.3 million individuals in the United States alone who are affected, a number expected to rise to 3.6 million by 2050. This rise in prevalence presents significant healthcare and economic challenges, necessitating innovative, data-driven solutions to improve patient care, quality of life (QOL) and healthcare equity. The National Institutes of Health (NIH) has taken a leading role in addressing these challenges by supporting the creation of a national registry to capture comprehensive data on limb loss and limb difference. This registry collects crucial patient information that helps inform both clinical care and research. Building on this, the not-for-profit community is now advancing these efforts forward, ensuring that data collection becomes a cornerstone of future advancements in this field of healthcare.Historically, limb loss and limb difference care have been constrained by fragmented and siloed data and outdated research. However, advances in data analytics are contemporizing the field by offering insights into patient outcomes and informing more effective healthcare policies. A registry allows for the consolidation of this data into valuable information, providing a holistic view of patient demographics, clinical outcomes and the effectiveness of treatments over time. Limb loss and limb difference place a substantial financial burden on individuals and healthcare systems, with lifetime healthcare costs averaging $509,275 for someone with limb loss, compared to $361,200 for those without

MediaNews4U
Oct 23rd, 2024
Mario Muredda Takes the Helm as Global CEO of Ogilvy Health

With over two decades of healthcare marketing experience, Muredda joins Ogilvy from Avalere Health, where he served as President of Marketing.